These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 8325957

  • 1. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro.
    Guise TA, Yoneda T, Yates AJ, Mundy GR.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):40-5. PubMed ID: 8325957
    [Abstract] [Full Text] [Related]

  • 2. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
    Uy HL, Mundy GR, Boyce BF, Story BM, Dunstan CR, Yin JJ, Roodman GD, Guise TA.
    Cancer Res; 1997 Aug 01; 57(15):3194-9. PubMed ID: 9242449
    [Abstract] [Full Text] [Related]

  • 3. Expression of human transforming growth factor alpha by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increased osteoclastic bone resorption.
    Yates AJ, Boyce BF, Favarato G, Aufdemorte TB, Marcelli C, Kester MB, Walker R, Langton BC, Bonewald LF, Mundy GR.
    J Bone Miner Res; 1992 Jul 01; 7(7):847-53. PubMed ID: 1642153
    [Abstract] [Full Text] [Related]

  • 4. Chinese hamster ovarian cells transfected with human parathyroid hormone-related protein cDNA cause hypercalcemia in nude mice.
    Guise TA, Chirgwin JM, Favarato G, Boyce BF, Mundy GR.
    Lab Invest; 1992 Oct 01; 67(4):477-85. PubMed ID: 1434529
    [Abstract] [Full Text] [Related]

  • 5. Increased production of tumor necrosis factor by normal immune cells in a model of the humoral hypercalcemia of malignancy.
    Sabatini M, Yates AJ, Garrett IR, Chavez J, Dunn JF, Bonewald L, Mundy GR.
    Lab Invest; 1990 Nov 01; 63(5):676-82. PubMed ID: 2232714
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
    Oyajobi BO, Anderson DM, Traianedes K, Williams PJ, Yoneda T, Mundy GR.
    Cancer Res; 2001 Mar 15; 61(6):2572-8. PubMed ID: 11289133
    [Abstract] [Full Text] [Related]

  • 7. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
    Sato K, Yamakawa Y, Shizume K, Satoh T, Nohtomi K, Demura H, Akatsu T, Nagata N, Kasahara T, Ohkawa H.
    J Bone Miner Res; 1993 Jul 15; 8(7):849-60. PubMed ID: 8352067
    [Abstract] [Full Text] [Related]

  • 8. Effects of parathyroid hormone (PTH)-related protein and PTH on osteoclasts and osteoclast precursors in vivo.
    Uy HL, Guise TA, De La Mata J, Taylor SD, Story BM, Dallas MR, Boyce BF, Mundy GR, Roodman GD.
    Endocrinology; 1995 Aug 15; 136(8):3207-12. PubMed ID: 7628353
    [Abstract] [Full Text] [Related]

  • 9. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E, Azuma Y, Saito H, Tsunenari T, Watanabe T, Hirabayashi M, Sato K, Yamada-Okabe H, Ogata E.
    Clin Cancer Res; 2005 Jun 01; 11(11):4198-203. PubMed ID: 15930357
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo.
    de la Mata J, Uy HL, Guise TA, Story B, Boyce BF, Mundy GR, Roodman GD.
    J Clin Invest; 1995 Jun 01; 95(6):2846-52. PubMed ID: 7769125
    [Abstract] [Full Text] [Related]

  • 11. Inhibition by human interleukin-1 alpha of parathyroid hormone-related peptide effects on renal calcium and phosphorus metabolism in the rat.
    Tørring O, Turner RT, Carter WB, Firek AF, Jacobs CA, Heath H.
    Endocrinology; 1992 Jul 01; 131(1):5-13. PubMed ID: 1319327
    [Abstract] [Full Text] [Related]

  • 12. Tumor resection and antibodies to parathyroid hormone-related protein cause similar changes on bone histomorphometry in hypercalcemia of cancer.
    Kukreja SC, Rosol TJ, Wimbiscus SA, Shevrin DH, Grill V, Barengolts EI, Martin TJ.
    Endocrinology; 1990 Jul 01; 127(1):305-10. PubMed ID: 2361475
    [Abstract] [Full Text] [Related]

  • 13. Parathyroid hormone-related protein and interleukin-1 alpha synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo.
    Sato K, Fujii Y, Kasono K, Ozawa M, Imamura H, Kanaji Y, Kurosawa H, Tsushima T, Shizume K.
    Endocrinology; 1989 May 01; 124(5):2172-8. PubMed ID: 2539970
    [Abstract] [Full Text] [Related]

  • 14. Dependence of humoral hypercalcemia of malignancy on parathyroid hormone-related protein expression in the canine anal sac apocrine gland adenocarcinoma (CAC-8) nude mouse model.
    Gröne A, Weckmann MT, Blomme EA, Capen CC, Rosol TJ.
    Vet Pathol; 1998 Sep 01; 35(5):344-51. PubMed ID: 9754539
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice.
    Nakano Y, Watanabe K, Morimoto I, Okada Y, Ura K, Sato K, Kasono K, Nakamura T, Eto S.
    J Bone Miner Res; 1994 Oct 01; 9(10):1533-9. PubMed ID: 7817798
    [Abstract] [Full Text] [Related]

  • 16. Effect of transforming growth factor alpha, parathyroid hormone-related protein, or their combination on bone histomorphometry.
    Kukreja SC, Rosol TJ, D'Anza JJ, Wimbiscus SA.
    Bone Miner; 1993 Nov 01; 23(2):105-11. PubMed ID: 8305876
    [Abstract] [Full Text] [Related]

  • 17. Copurification of osteolytic and transforming growth factor beta activities produced by human lung tumor cells associated with humoral hypercalcemia of malignancy.
    Linkhart TA, Mohan S, Jennings JC, Baylink DJ.
    Cancer Res; 1989 Jan 15; 49(2):271-8. PubMed ID: 2535957
    [Abstract] [Full Text] [Related]

  • 18. Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice.
    Johnson RA, Boyce BF, Mundy GR, Roodman GD.
    Endocrinology; 1989 Mar 15; 124(3):1424-7. PubMed ID: 2917519
    [Abstract] [Full Text] [Related]

  • 19. Effects of transforming growth factor-alpha on parathyroid hormone- and parathyroid hormone-related protein-mediated bone resorption and adenylate cyclase stimulation in vitro.
    Rosol TJ, Merryman JI, Nohutcu RM, McCauley LK, Capen CC.
    Domest Anim Endocrinol; 1991 Oct 15; 8(4):499-507. PubMed ID: 1786699
    [Abstract] [Full Text] [Related]

  • 20. EGF receptor antiserum inhibits bone resorbing activity produced by a rat Leydig cell tumor associated with the humoral hypercalcemia of malignancy.
    Ibbotson KJ, D'Souza SM, Smith DD, Carpenter G, Mundy GR.
    Endocrinology; 1985 Jan 15; 116(1):469-71. PubMed ID: 2981075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.